In contrast to these effects, treatment of 2 independent grade 1 tumor cell lines with the TGFβ inhibitor - SB431542, induced up to 2-fold increase in BST2 (p<0.01) (Figure 3C). This evidence concerns the gene TGFB1 and neoplasm.